MoneyWorks4Me

Gland Pharma informs about analyst meet

20 Sep 2023 Evaluate
Pursuant to Regulation 30 read with Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, Gland Pharma has informed that it enclosed the schedule of the Analyst/ Institutional Investor Meeting with the Company to be 25th September 2023.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1861.70
Dr. Reddys Labs. 1216.10
Cipla 1378.15
Lupin 2118.00
Zydus Lifesciences 1170.00
View more..